People who start HIV meds with a very low CD4 count can get a quick
immune boost by taking interleukin-2 (IL-2), a new Italian study has
found. Experts have long known that IL-2 (which is not an approved HIV
therapy) acts as an immune booster, but side effects and other issues
have prevented it from going into widespread use. This new study found
that people who took three courses of IL-2 within the first three
months of starting HIV meds had a faster, greater increase in CD4
count and developed fewer opportunistic illnesses than participants
who took HIV meds alone. However, the study also notes that the
benefit appears strictly short-term: A year and a half after the
study started there was no difference in CD4 count between the people
who took IL-2 and those who did not.
Tags:
Share
You need to be a member of Youth Awareness Movement Against AIDS In Africa. to add comments!
Join this Ning Network